Journal of Renal Nutrition
Volume 19, Issue 4 , Pages 334-342 , July 2009

Adherence to K/DOQI Bone Metabolism Guidelines

  • David H. Smith, RPh, PhD

      Affiliations

    • Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon
    • Corresponding Author InformationAddress reprint requests to David H. Smith, RPh, PhD, Center for Health Research, Kaiser Permanente Northwest, 3800 N. Interstate Ave., Portland, OR 97227.
    • ,
  • Eric S. Johnson, PhD

      Affiliations

    • Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon
    • ,
  • Micah L. Thorp, DO, MPH

      Affiliations

    • Department of Nephrology, Kaiser Permanente Northwest, Portland, Oregon
    • ,
  • Xiuhai Yang, MS

      Affiliations

    • Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon

References 

  1. Eastwood JB, Stamp TC, Harris E, et al. Vitamin-D deficiency in the osteomalacia of chronic renal failure. Lancet. 1976;2:1209–1211
  2. Ishimura E, Nishizawa Y, Inaba M, et al. Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int. 1999;55:1019–1027
  3. London GM, Guerin AP, Marchais SJ, et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003;18:1731–1740
  4. Tomiyama C, Higa A, Dalboni MA, et al. The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients. Nephrol Dial Transplant. 2006;21:2464–2471
  5. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(Suppl):S1–S201
  6. Manjunath M, Sarnak M, Levey A. Prediction equations to estimate glomerular filtration rate: an update. Curr Opin Nephrol Hypertens. 2001;10:785–792
  7. DeFrances CJ, Podgornik MN. 2004 National Hospital Discharge Survey. Adv Data. 2006;371:1–19
  8. Avorn J, Bohn RL, Levy E, et al. Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med. 2002;162:2002–2006
  9. Winkelmayer WC, Levin R, Avorn J. The nephrologist's role in the management of calcium-phosphorus metabolism in patients with chronic kidney disease. Kidney Int. 2003;63:1836–1842
  10. Keith DS, Nichols GA, Gullion CM, et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659–663
  11. United States Renal Data System . USRDS 2006 annual data report: atlas of end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006;
  12. Chernew M. HMO use of diagnostic tests: a review of the evidence. Med Care Res Rev. 1995;52:196–222
  13. Wang YR, Pauly MV. Difference in the use of preventive services between fee-for-service plans and HMOs: is more better?. Am J Manag Care. 2003;9:293–301

 This study was supported by Amgen.

PII: S1051-2276(09)00035-1

doi: 10.1053/j.jrn.2009.01.013

Journal of Renal Nutrition
Volume 19, Issue 4 , Pages 334-342 , July 2009

Article Tools

* Image Usage & Resolution